Skip to content

all-sanfrancisco.com

  • Education
  • World News
  • Business
  • Economy
  • Politics
  • Analysis & Comment

Home » HORIZON

2021-02-01 Comments Off on Horizon Therapeutics boosts rare-disease portfolio with $3.05 billion Viela Bio buy

Horizon Therapeutics boosts rare-disease portfolio with $3.05 billion Viela Bio buy

(Reuters) – Horizon Therapeutics plc has agreed to buy Viela Bio Inc for about $3.05 billion as it looks to

Recent Posts
  • Trump opens 2024 run, says hes more committed than ever The Denver Post
  • Opinion | A.I.: Actually Insipid Until It’s Actively Insidious
  • Colorado rural residents get health care assistance from state program
  • Sicko who broke into church to watch adult content caught by mess left on PC
  • Brit boy, 8, struck by lightning on beach during family holiday to Australia
Business News:
2023-01-27

Chipotle looks to hire 15,000 amid continuing labor shortage

2023-01-18

Southwest pilots plan vote to authorize strike after holiday travel chaos The Denver Post

2023-01-07

Colorado State opens last building on National Western grounds

2023-01-04

Wall St reverses losses as focus turns to Fed minutes

Copyright © 2023